Skip to Main Content

Paper Details

Inhibition of DHCR24 activates LXRα to ameliorate hepatic steatosis and inflammation.
EMBO Mol Med
7
2023
24-dehydrocholesterol, 24-dehydrocholesterol reductase, APOE*3-Leiden, CETP, DHCR24, Desmosterol, Kupffer cell, LXR, LXR deficiency, Liver X receptor, NAFLD, NASH, SH42, alanine, cholesterol, cholesteryl ester, collagen, desmosterol, fatty acid, hepatic steatosis, human, hyperlipidemia, inflammation, liver inflammation, mice, monocyte, plasma alanine transaminase, steatosis
Author NameAffiliation
Yassene MohammedThe Center for Proteomics and Metabolomics, Leiden University Medical Center
Folkert KuipersUniversity of Groningen, University Medical Center Groningen
Folkert KuipersUniversity of Groningen, University Medical Center Groningen
Christopher K GlassUniversity of California San Diego
Christopher K GlassUniversity of California San Diego
  • 1 - 5

Datasets

Release 1.2